mynth
← DATABASE
10/2024100%

Rupa Health acquired by Fullscript

UNITED STATES Healthcare Services / Health Tech REV 1m EUR - 100m EUR

Context

The acquisition of Rupa Health by Fullscript executes a strategic consolidation within the digital healthcare and diagnostic testing sectors. Announced in October 2024, this corporate transaction orchestrates the complete integration of a specialized laboratory logistics portal into a broader whole person care ecosystem. By formally absorbing the acquired technology, the Canadian buyer captures a highly complementary digital asset that directly bridges the operational gap between diagnostic testing and therapeutic supplementation. The structural integration merges an extensive external catalog of specialty diagnostic tools directly with the buyer's established treatment planning software, creating a unified clinical interface capable of gathering, analyzing, and actioning patient data seamlessly. The strategic rationale guiding the acquiring executive board explicitly focuses on establishing the preeminent digital site where diverse healthcare practitioners can manage both their laboratory ordering workflows and therapeutic dispensing from a single centralized dashboard. This combined software architecture eliminates the need for medical clinics to utilize disparate systems for diagnostics, results management, and physical interventions. The newly consolidated entity aims to empower medical providers to deliver highly personalized, evidence-based care by improving immediate access to critical diagnostic insights, decision-support tools, and continuing medical education resources. Throughout the post-transaction integration phase, the acquired academic and multimedia modules will strictly enhance the overarching value proposition offered to the acquirer's established network of medical professionals. This alignment internalizes the required data infrastructure to practice root-cause medicine at a massive scale, optimizing health outcomes for patient populations by streamlining administrative friction and standardizing patient communication. Ultimately, the definitive agreement structurally transforms the buyer into an end-to-end medical care ecosystem capable of supporting comprehensive chronic disease management and preventive health protocols across diverse care specialties and complex clinical conditions.

Rupa Health, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in Healthcare & Pharma market trends

Target

Launched in 2020 by co-founders Tara Viswanathan and Rosa Hamalainen, Rupa Health operates as a specialized digital health platform designed to modernize the logistics of laboratory testing. The healthcare technology company manages a comprehensive diagnostic infrastructure that allows medical practitioners to order, track, and manage more than 3,000 distinct specialty lab tests through a single unified interface. By integrating test ordering workflows, results management, and direct patient communication protocols, the enterprise serves an active network encompassing tens of thousands of clinics across the United States. Furthermore, the organization actively supports half a million patients and practitioners every month by centralizing critical diagnostic insights. Beyond its core laboratory logistics software, the entity directs a dedicated educational division operating under the name Rupa University. Through this specialized academic arm, the company has formally trained tens of thousands of healthcare professionals via live classes and educational bootcamps focused on personalized, root-cause medical practices. The corporate ecosystem also produces specialized multimedia resources, explicitly including the Rupa Magazine and the Root Cause Medicine Podcast, to further distribute clinical education.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
€1–100M
[members only]
[members only]
2023
€1–100M
[members only]
[members only]

Other operations with Fullscript

Other operations with Fullscript
DateAcquirerTargetCountrySector
09/2026L CATTERTON / ALTAS PARTNERSFULLSCRIPTCANADAHealthcare

Similar deals in Healthcare Services

Similar deals in Healthcare Services
DateAcquirerTargetCountrySector
04/2025KERSIANEOGEN (ANIMAL BIOSECURITY DIVISION)UNITED STATESSterilization & Hygiene
04/2025TRANSCARENTACCOLADEUNITED STATESHealth Tech
07/2024ARDIANMASCO GROUPITALYHealthcare Services
06/2024PERMIRAPHARMACORDUNITED STATESHealth Tech
05/202421 INVEST / OAKLEY CAPITAL INVESTMENTSPRODUCT LIFEFRANCEHealthcare Services
10/2023MOTION EQUITY PARTNERSBANOOKFRANCECRO / Clinical Trials
09/2023PERMIRAERGOMEDUNITED KINGDOMCRO / Clinical Trials
09/2023CERBA HEALTHCARECIRION BIOPHARMA RESEARCHCANADACRO / Clinical Trials
06/2023SUPERNOVA INVEST / HEAL CAPITALGLEAMERFRANCEHealth Tech
06/2022ASTORGOPEN HEALTHUNITED STATESHealthcare Services

REFERENCES

Revenue range: REV 1m EUR - 100m EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Rupa Health by Fullscript are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: rupa health

FAQ

What transaction does this page cover?

This page covers Fullscript’s acquisition of 100% of Rupa Health, an American company specialised in Health Tech, in 2024.

What sources support the information on this transaction?

The details of this transaction are sourced directly from the official corporate announcement published on the parties’ institutional website, ensuring primary-source verification of the closing and perimeter.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.